Attacks on the life sciences and healthcare sectors (healthcare providers and health technology, medical device, pharmaceutical and biotechnology companies) increased dramatically over the last year, even at the World Health Organization, that reported a substantial increase in attacks in 2020. Moreover, the life sciences industry was the biggest target of intellectual property theft by hostile cyberspace assaults, ultimately costing the US billions of dollars. With the constant push to create vaccines and medicinal cures throughout the globe, the hazards show no signs of receding.
At SubRosa, we recognize the distinctive challenges the life sciences industry faces when it comes to cybersecurity. With the rapid advancements in biotechnology, genetic research, and medical devices, the volume of sensitive and proprietary data generated is immense. The protection of this data is of paramount importance, making robust cybersecurity measures vital for every life sciences organization.
The life sciences industry, encompassing areas such as pharmaceuticals, biotechnology, and medical devices, holds a wealth of sensitive data. This includes patient information, genetic data, clinical trial data, intellectual property, and more. These valuable assets make the industry an attractive target for cybercriminals, resulting in potentially disastrous impacts, such as patient safety risks, loss of intellectual property, regulatory penalties, and damage to brand reputation.
Moreover, the industry's embrace of digital technologies like AI, cloud computing, and IoT has created new vulnerabilities and complex risk scenarios. Therefore, a responsive, agile, and comprehensive cybersecurity strategy is indispensable.
There is a huge interest in the Life Science business from a wide variety of threat actors: Malicious actors are attracted to the Life Science industry as the industry manages substantial quantities of cash. There are hacktivists and extreme hackers who believe that the industry’s activities are immoral. While foreign nations may try to disrupt essential medicine and treatment supplies or steal technology to assist their own local enterprises compete.
Furthermore, companies in the Life Sciences sector often have access to highly confidential data about their clients’ goods and research. The whole value stream of Life Science enterprises, from research & innovation to manufacturing and distribution, is largely dependent on technology and the availability of data. In consequence, primary data integrity is vital to Life Science businesses as they strive to introduce novel treatments and products and keep regulatory approval. The need of maintaining strict confidentiality is underscored by the nature of the work being done in this field.
A plethora of individually identifiable information and extremely sensitive health information is held by some Life Science organizations, and this information is becoming increasingly useful to thieves. Many clinical trial data are anonymized, but data is gathered at the adverse event management stage and as part of patient support programs, and the number is rapidly increasing. This data is used across the value chain in clinical trials.
SubRosaoffers a range of cybersecurity solutions designed specifically for the life sciences industry. Our team of experts has an in-depth understanding of the industry and the unique security vulnerabilities it faces.
Our services include:
At SubRosa, we are committed to securing the future of the life sciences industry. We aim to not only protect your data today but to build a resilient security infrastructure that can withstand future challenges.In the life sciences industry, ensuring the safety of your digital assets and maintaining patient trust are critical. Reach out to us today to see how we can help secure your business.
Attacks on the life sciences and healthcare sectors (healthcare providers and health technology, medical device, pharmaceutical and biotechnology companies) increased dramatically over the last year, even at the World Health Organization, that reported a substantial increase in attacks in 2020. Moreover, the life sciences industry was the biggest target of intellectual property theft by hostile cyberspace assaults, ultimately costing the US billions of dollars. With the constant push to create vaccines and medicinal cures throughout the globe, the hazards show no signs of receding.
At SubRosa, we recognize the distinctive challenges the life sciences industry faces when it comes to cybersecurity. With the rapid advancements in biotechnology, genetic research, and medical devices, the volume of sensitive and proprietary data generated is immense. The protection of this data is of paramount importance, making robust cybersecurity measures vital for every life sciences organization.
The life sciences industry, encompassing areas such as pharmaceuticals, biotechnology, and medical devices, holds a wealth of sensitive data. This includes patient information, genetic data, clinical trial data, intellectual property, and more. These valuable assets make the industry an attractive target for cybercriminals, resulting in potentially disastrous impacts, such as patient safety risks, loss of intellectual property, regulatory penalties, and damage to brand reputation.
Moreover, the industry's embrace of digital technologies like AI, cloud computing, and IoT has created new vulnerabilities and complex risk scenarios. Therefore, a responsive, agile, and comprehensive cybersecurity strategy is indispensable.
There is a huge interest in the Life Science business from a wide variety of threat actors: Malicious actors are attracted to the Life Science industry as the industry manages substantial quantities of cash. There are hacktivists and extreme hackers who believe that the industry’s activities are immoral. While foreign nations may try to disrupt essential medicine and treatment supplies or steal technology to assist their own local enterprises compete.
Furthermore, companies in the Life Sciences sector often have access to highly confidential data about their clients’ goods and research. The whole value stream of Life Science enterprises, from research & innovation to manufacturing and distribution, is largely dependent on technology and the availability of data. In consequence, primary data integrity is vital to Life Science businesses as they strive to introduce novel treatments and products and keep regulatory approval. The need of maintaining strict confidentiality is underscored by the nature of the work being done in this field.
A plethora of individually identifiable information and extremely sensitive health information is held by some Life Science organizations, and this information is becoming increasingly useful to thieves. Many clinical trial data are anonymized, but data is gathered at the adverse event management stage and as part of patient support programs, and the number is rapidly increasing. This data is used across the value chain in clinical trials.
SubRosaoffers a range of cybersecurity solutions designed specifically for the life sciences industry. Our team of experts has an in-depth understanding of the industry and the unique security vulnerabilities it faces.
Our services include:
At SubRosa, we are committed to securing the future of the life sciences industry. We aim to not only protect your data today but to build a resilient security infrastructure that can withstand future challenges.In the life sciences industry, ensuring the safety of your digital assets and maintaining patient trust are critical. Reach out to us today to see how we can help secure your business.
SubRosa is a cybersecurity solutions provider specializing in cyber assessments and risk and compliance.
